Chemical Biology & Drug Design · 2019 · 10 citations · 11 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyEnzyme InhibitionHypoxia AdaptationVirtual ScreeningBiological Assay ValidationBiological ValidationErythropoiesis Under HypoxiaErythropoiesis-stimulating TherapyErythropoietic Response To HypoxiaErythropoietin RegulationHif-2 Alpha RegulationVirtual Screening Validation
Hypoxia-inducible factor (HIF) is identified to be a promising target to mediate the response to hypoxia. Its stability and activation are negatively controlled by prolyl hydroxylase 2 (PHD2). Thus, PHD2 inhibition has been perceived as a promising anti-anemia therapy. In this study, we carried out a structure-based virtual screening followed by in vitro and in vivo biological validation, with the goal to identify novel PHD2 inhibitors. As a result, a set of hits with new chemical scaffolds were revealed to be active in vitro for PHD2 inhibition. Compounds 2 and 3 were revealed to be capable of stabilizing HIF-α and stimulating erythropoietin (EPO) expression in cell-based assays. Notably, further in vivo assays revealed that 2 was capable of elevating the EPO plasma levels in C57BL/6 mice model. These findings provide new chemical scaffolds for further development of PHD2 inhibitors.
11
Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
Jung-Hyun Min, Haifeng Yang, Mircea Ivan et al. · Science · 2002 · 770 citations
Carles Galdeano, Morgan S. Gadd, Pedro Soares et al. · Journal of Medicinal Chemistry · 2014 · 403 citations · Full text
Petr Váchal, Shouwu Miao, Joan M. Pierce et al. · Journal of Medicinal Chemistry · 2012 · 66 citations · Full text